Top Markets
#1 MowCat MowCat +49.48%
#2 Velvet Velvet +22.01%
#3 Block Street Block Street +17.94%
#4 Perle Perle +17.51%
#5 Quack AI Quack AI +16.48%
#6 Fake World Assets Fake World Assets +16.44%
#7 Derive Derive +14.43%
#8 Bermuda Shorts Bermuda Shorts +13.97%
#9 Epic Chain Epic Chain +13.90%
#10 DUSK Network DUSK Network +12.90%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc.

OBLN
Rank in Stocks #34657
Obalon Therapeutics, Inc. operates as a fully integrated medical device... Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter. It also includes the Obalon Navigation System console, a specialized hardware and software platform used to precisely monitor and display the balloon's location during its placement. Further components are the Obalon Touch Inflation Dispenser, a semi-automated, portable instrument for inflating the balloon once it's correctly positioned, and a single-use canister containing a gas mixture. By February 27, 2020, Obalon Therapeutics managed three company-owned treatment centers situated in California. The firm was established in 2008 and bases its operations in Carlsbad, California.
Share Price
$3.05
Last synced: 2021-06-15
Market Cap
$5.16M
Change (1 day)
-5.86%
Change (1 year)
0.00%
Country
US
Trade Obalon Therapeutics, Inc. (OBLN)

Category

Healthcare
Operating Margin for Obalon Therapeutics, Inc. (OBLN)
Operating Margin as of 2026 TTM: 0.00%
According to Obalon Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Obalon Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
28.09% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.